Featured Editorial

31. Managing Customs, Import/Export Requirements, And Cross-Border Logistics Challenges 8/10/2026

    Customs delays can derail clinical trials in days. Learn practical strategies for import compliance, digital preclearance, and resilient cross-border logistics.

32. July Update — U.S. Generic Drug Tariffs: Implications For Pharma And Outsourcing 8/7/2026

    Mathini Ilancheran updates us on how delayed U.S. tariffs on generic drug imports could reshape supply, sourcing, and trial planning.

33. Fast, Secure, And Defensible: Building Decisions That Can Be Challenged Internally And Defended Externally 8/7/2026

    When clinical supply decisions face uncertainty, speed alone is not enough. Learn how governance frameworks create faster, more secure, and defensible actions.

34. Cold Chain Excellence: Safeguarding Biologics, Cell Therapies, And Temperature-Sensitive Products In Complex Logistics 8/6/2026

    Cold chain failures can destroy biologics and cell therapies. Learn how real-time monitoring, validated packaging, and lane qualification reduce risk and protect patients.

35. Why Ending Rh Disease Requires More Than A Breakthrough (Part 3 of 3) 8/5/2026

    Rh disease has been preventable for decades. Yet babies still die worldwide because access, supply, and infrastructure have not caught up.

36. How AI Can Improve Clinical Supply Chain Visibility 8/5/2026

    AI can help clinical supply teams identify risks earlier, improve forecasting, and make faster, more informed decisions before disruptions affect trial continuity.

37. The Overlap Nobody Talks About: Packaging Decisions And Stability Budgets 8/4/2026

    Packaging decisions shape far more than product protection. Discover how stability budgets and temperature excursion planning can prevent waste and reduce trial risk.

38. The Biggest Early-Stage Clinical Supply Mistake? Building Too Much, Too Soon. 8/3/2026

    Early-stage biotechs often overbuild systems too soon. Alicia Collins, of Tune Therapeutics, explains why flexibility, simple processes, and realistic assumptions matter most.

39. Study Start-Up Is Where Clinical Supply Risk Is Actually Decided 8/3/2026

    Clinical supply risk begins long before the first shipment. Learn how study start-up decisions shape forecasting, inventory, manufacturing, and trial execution.

40. How Clinical Supply Is Shaping The Next Generation Of Cell And Gene Therapies 7/31/2026

    From CAR-T to gene editing, clinical supply realities are increasingly influencing therapeutic design, scalability, and patient access.